Global Sacral Nerve Stimulation Market 2017-2021

  • ID: 4070549
  • Report
  • Region: Global
  • 63 pages
  • TechNavio
1 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.

The analysts forecast the global sacral nerve stimulation market to grow at a CAGR of 4.66% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global sacral nerve stimulation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume, and value of SNS devices.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Sacral Nerve Stimulation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Medtronic

Other prominent vendors
- Axonics Modulation Technologies
- Nuvectra

Market drivers
- Increasing R&D efforts by companies in SNS market
- For a full, detailed list, view the full report

Market challenges
- Unfavorable reimbursement scenario for SNS procedures
- For a full, detailed list, view the full report

Market trends
- O-arm guided navigation in patients with partial sacral agenesis
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction
  • Key market highlights
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product
  • Implantable SNS devices
  • External SNS devices
Part 07: Market segmentation by end-user

Part 08: Geographical segmentation
  • SNS market in Americas
  • SNS market in EMEA
  • SNS market in APAC
Part 09: Market drivers
  • Increasing geriatric population with sacral nerve issues
  • Increasing R&D efforts by companies in SNS market
  • Untapped emerging countries for SNS adoption
Part 10: Impact of drivers

Part 11: Market challenges
  • Side-effects concerned with use of SNS devices
  • Magnetic sphincter augmentation posing a threat to SNS in treating severe fecal incontinence
  • Unfavorable reimbursement scenario for SNS procedures
Part 12: Impact of drivers and challenges

Part 13: Market trends
  • O-arm guided navigation in patients with Partial sacral agenesis
  • Bioabsorbable antibacterial technology to minimize the postsurgical infections
  • Increasing potential use of SNS devices in emerging indications
Part 14: Vendor landscape
  • Competitive scenario
  • Medtronic
  • Other prominent vendors
  • Appendix
  • List of abbreviations
Part 15: About the Author

List of Exhibits

Exhibit 01: Global SNS market: Overview
Exhibit 02: Global SNS market 2016-2021 ($ million)
Exhibit 03: Five forces analysis
Exhibit 04: Global implantable SNS market 2016-2021 ($ million)
Exhibit 05: Implantable SNS devices: Market analysis
Exhibit 06: Global external SNS market 2016-2021 ($ million)
Exhibit 07: External SNS devices: Market analysis
Exhibit 08: Global SNS market share by end-users
Exhibit 09: Global SNS market by geography 2016-2021 (% revenue)
Exhibit 10: SNS market in Americas: Overview
Exhibit 11: SNS market in Americas 2016-2021 ($ million)
Exhibit 12: SNS market in EMEA: Overview
Exhibit 13: SNS market in EMEA 2016-2021 ($ million)
Exhibit 14: SNS market in APAC: Overview
Exhibit 15: SNS market in APAC ($ million)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Market enablers for TYRX
Exhibit 19: Competitive structure analysis of global SNS market 2016
Exhibit 20: Market penetration of key SNS device manufacturers 2016
Exhibit 21: Game changing strategies for new entrants
Exhibit 22: Medtronic: Strength assessment
Exhibit 23: Medtronic: Strategy assessment
Exhibit 24: Medtronic: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

New Report Released: - Global Sacral Nerve Stimulation Market 2017-2021

The author of the report recognizes the following companies as the key players in the global sacral nerve stimulation market: Medtronic.

Other Prominent Vendors in the market are: Axonics Modulation Technologies and Nuvectra.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is O-arm guided navigation in patients with partial sacral agenesis. SNS lead implantation is a direct procedure for patients with intact spinal vertebrae. Anorectal malformations are usually associated with congenital sacral deformity. In case of sacral anomalies, the anatomical and radiological reference points used in placing the electrode may be difficult to identify or even absent.”

According to the report, one of the major drivers for this market is increasing R&D efforts by companies in SNS market. Medtronic has a monopoly in the SNS market, with both implantable and external SNS devices in its portfolio. There are other companies focusing on this market by investing in R&D to launch new devices.

Further, the report states that one of the major factors hindering the growth of this market is unfavorable reimbursement scenario for SNS procedures. In the recent years, medical facilities across different geographical regions have been using SNS devices in the management of gastrointestinal and urological disorders like fecal and urinary incontinence. However, unfavorable reimbursement policies govern these products, requiring people to bear out-of-pocket expenses for SNS devices and accessories.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

  • Medtronic
  • Axonics Modulation Technologies
  • Nuvectra
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll